Professional Documents
Culture Documents
HISTORY
1. The Quantum Theory:
Max Planck
1910
Light is quantified in Photon units
the basic unit of light (6.625 x 10-27 erg sec (cm2/sec))
2. Stimulated Emission Theory:
Albert Einstein
1917
Basis of laser light
3. First laser developed, demonstrated and patented
Theodore Maiman
Ruby Laser
1960
UNITS OF MEASUREMENT
1. Frequency Expressed in Cycles per Second (CPS)
Hertz (Hz)
2. Wavelength The measurement of one crest to another of a particular frequency
Coherent = All crests of wavelengths line up. Crests and troughs are equidistant in
time and space. This eliminates wavelengths canceling each other out and producing
interference patterns which would decrease its intensity. This enables very efficient
power production. Coherent light, (compared with incoherent, conventional light) can be
focused to an exact single point. ie: 200 W of incoherent conventional light will illuminate
a room. 200 W of coherent laser light will rapidly carve through the cement wall of the
room.
Collimated = Emitted stream of photons is linear, and does not diverge. This also
eliminates wavelengths producing interference patterns reducing power.
COMPONENTS OF A LASER
1. Partially reflecting mirror 97%
2. Fully reflecting mirror 100%
3. Lasing media
4. Xenon flash lamp
5. high frequency Switching system
6. High voltage power supply
7. Delivery system - Articulating Arm, Fiberoptic, waveguide 8. Lense
9. Aiming Laser (HeNe), if required, depends on laser type
DELIVERY MECHANISMS
1. Low frequencies = longer wavelengths = far- and mid-infrared.
Articulating arms, or internally reflecting waveguides are used.
2. At near-infrared, 2100 nm and above (Ho:YAG laser) fiberoptics contain these
frequencies having a higher index of refraction.
3. Fiberoptics are constructed of quartz (Aluminum dioxide), silicon dioxide or silver
halides, coated with a plastic sheath.
4. Lenses, or contact light scalpels of selective focal lengths, can be integrated into the
terminal end of the fiberoptic system.
5. The bare fiber is also used for free beam ablation work.
TRANSMISSION MODES
1. Desirable laser energy distribution energy follows a Gaussian curve.
2. Energy decay falls exponentially on either side of the curve.
TEM00 has a narrow spot size TEM01 small spot 0.3 mm at best
true Gaussian
curve.
called "near
Gaussian"
0.2 mm diameter
spots
not desirable
appropriate for
cutting
can be used
for ablation.
TISSUE
INTERACTION
1. This is THE most important aspect of lasers in medical science.
2. Tissue interaction with the specific laser wavelength is the KEY to laser selection.
POWER DENSITY
1. Is the standard of expression in documenting laser power to tissue.
2. Expressed in W/cm2.
3. P.D. maybe constant while tissue spot size and power varies.
This allows physicians to communicate standard terminology, allows for preference. It is
the STANDARD OF CARE: in operative reports describing laser use
It is necessary for communicating standard measurement in the scientific community.
A typical example using 14 Watts with a 0.2 mm diameter contact tip or spot size (which
is 0.1 mm radius)
Traditional Algebraic:
WATTS 14 4.46 446
----------- = --------------------- = ----------------- = --------------------- = 44,600
pi x r2 0.12 0.01 0.01
3.14 x ----- -----
102 100
a shortcut algebraic:
WATTS 14
127 x ----------- = 127 x --------- = 44,450
d2 0.22
WATTS PER CM2 Chart
TIME
The gating of the flash lamp may be:
1. C.W. Continuous Wave - Continuously on
2. Single Pulsed - Continuous on for a preset period
3. Superpulsed - Rapid pulsing at peak power at 250 - 1000 Hz.
Average power is determined by
1. pulse width and
2. repetition rate
This allows tissue to undergo "thermal relaxation"
4. Ultrapulsed - Much higher RF (Radio Frequency) switching
nanosecond pulse width.
More thermal precision.
5. Q-switched - Very high peak power with picosecond pulse width
EYE PROTECTION
1. Impact is direct or reflective.
2. Minimal hazard zone is determined to be 6 feet away from the reflected zone.
3. O. D. = Optical Density, expressed as an exponent of power of 10.
ie: O. D. of 5 is 100 x as absorbent as O. D. of 3
4. Always expressed as an O.D. at a specific wavelength
5. Recommended to surgeon (direct viewing field) - minimum O.D. of 5 @ wavelength.
6. Recommended to OR personnel (indirect) - minimum O.D. of 3 @ wavelength.
7. Conventional glass or plastic glasses will stop CO2
8. Recommend UV coating to stop the ultraviolet fluorescence off carbonization.
9. Eye protection still necessary for endoscopic procedures, fibers could break.
10. High density filters on endoscopes, arthroscopes, waveguides.
11. The reflected light transmits directly back to the surgeon.
High power plume evacuators are required with dual stage filters.
1. Charcoal filter for carcinogens, smell.
2. Filtering down to 0.2 microns to filter out virus
a. The key is good technique in smoke evacuation.
b. Keep the smoke evacuator close to the area of surgery.
c. A laser mask will filter down to 0.3 microns.
d. These measures reduce nearly all of the hazards of the viral particles
STANDARD OF CARE
1. OPERATIVE REPORT - Include laser type power density calculation.
ie: "Procedure: Austin Bunionectomy, left foot (Soft tissue with CO2 laser): With the CO2
laser set at 33,000 W/cm2 power density, a linear incision was ..."
2. CONSENT FORM - Include the laser type or wavelength used and the intended
application of the laser if there is conventional instrumentation used. ie: "(Usual
description of surgery), soft tissue with CO2 laser"
Advertise straightforward what laser procedures (warts, nails) are done if also
advertising conventional procedures (bunionectomy) that are not performed with laser
assistance.
DISADVANTAGES
1. Cost, power, alignment, control, additional informed consent
2. Smoke evacuation system
3. Combustible materials risk, extra drapes, higher protection
4. Special training for physician/staff
5. Learning curve
6. Credentialling process/extension of privileges if hospital use
The following diagrams, illustrate two methods: linear and circular overlap.
The goal is an evenly ablated surface.
1. Circumscribe lesion by 2 mm peripherally
2. Curette representative area and send biopsy for pathology.
3. Deep channels should be avoided.
4. Do not penetrate dermis in verrucoid lesions.
5. If you have a 0.2 mm spot size at focal point, defocus to 1.0 mm.
For example, 20 watts with a 1 mm spot size equals 2540 watts/cm2 power density.
Scarring results from dermal penetration
IPK's and porokeratosis are focally penetrated to the dermis.
1. Need to lase to subdermal fat.
2. 75% cure rate, somewhat higher than conventional applications.
3. Little scarring.
4. More focal treatment is required at higher power levels.
5. Remove char by lavage or sponge
NOTES:
1. A TEM00 laser produces a very different effect compared to a TEM01 machine
2. A superpulsed laser has a variety of pulse settings to achieve the same P. D.
3. The ultrapulsed lasers cut faster at lower power settings.
4. These are characterized by very short duration RF pulsed power supplies
HEMOSTASIS
1. By Coagulation:
Defocus to a spot size greater than twice the vessel diameter
Use a Power density less than 1500 watts/cm2
Technique: defocus beam to increase spot size and direct beam at site
2. By Dessication (thermal contraction):
Spot size 1 mm
Power density as with coagulation
Technique: direct beam to tissue immediately adjacent
OVERLASING
Significant problem to inexperienced user is "Overlasing"
Definition: delivery of an inappropriate amount of laser energy to target tissue
or to the surrounding tissues
producing unintended tissue destruction.
(Immediately visualized with CO2 lasers.)
CAVERNOUS HEMANGIOMA
1. Considered ablative surgery requiring high power densities.
2. This is a highly vascular tumor.
3. Nd:YAG (bare fiber) is appropriate for deep penetration
4. Causes deep thermal vascular stenosis.
5. CO2 is not good for coagulation for these tumors, but it can be used.
6. KTP and Argon are more appropriate for superficial vascular lesions.
Postoperative Care:
1. Patient seen 3 days to 1 week
2. Patient allowed to clean twice daily with H202 and bandaid
exception: large lesions require redressing until drainage decreases.
3. Normal bathing after first redressing.
Accommodative pad if needed.
4. Stop dressing when drainage ceases, no dressing at night.
5. Monitor patient for at least 6 months due to the nature of HPV.
6. Success rate easily 90% after learning curve reached.
Complications:
1. Infection--rare, laser sterilizes the bed.
2. Overlasing
NOTES:
3. Increased pain--result of overlasing.
4. Increased bleeding--result of overlasing
5. Increased scarring--result of overlasing
6. Scarring--Penetration of dermis
1. Techniques for missing part of the matrix are just a probable with laser or blade
2. Characterized as a blind procedure.
3. Burning bone may result in periostitis, very rare.
4. Recurrence after learning curve partial permanent procedure, hallux, 0.5%.
5. These rate of results after learning curve reached.
6. Usually recurrence is keloid, hypertrophic scar formers, and psoriatic patients
7. Patients with high epidermal growth turnover
8. Total permanent if recurrent in these patients
POSTOPERATIVE CARE
1. Leave sterile dressing on 24 h
Patient to change at home
Patient to clean twice daily with H202. No soaks.
2. Some tissue necrosis 1 week
3. Patient to keep dry for 3 days
4. Patients seen 24 hours - 3
days postop
5. Bandaid dressing
6. Normal healing
7. Discontinue dressing and soaks
when drainage ceases, generally 2 weeks
8. Allow it to drain 1-3 weeks until it stops draining spontaneously.
9. Total permanent drain more on the 3 week margin, lesser digit partials for a week or
so.
COMPLICATIONS
1. Increased pain
2. Increased drainage
3. Delayed healing
4. Soft tissue infection
5. Thermal osteitis
6. Osteomyelitis
7. Overlasing is generally the culprit of all those complications.
PREVENTION OF COMPLICATIONS
1. Use appropriate power density
2. Keep the hand piece moving or apply power with periodicity
3. Keep exposure time on a given spot to a minimum
4. Don't relase over char
5. Always know where the beam is going, especially these blind procedures
SUBTOTAL MATRIXECTOMY
1. Anesthesia as before
2. The plate is always removed conventionally
3. Lasing is performed on the total matrix
4. however only scanned to 50% of the depth
5. The idea is to remove only part of the nail matrix to result in a thinner nail
SUBUNGUAL HEMATOMA
1. No anesthesia
2. Same procedure as mottling technique
3. Slightly higher power Density may be used
4. Lase a couple of holes until the nail plate is penetrated.
5. Hematoma will isolate thermal effects.
GENERAL DESCRIPTION
1. 1060 nm, near-infrared, separate HeNe aiming beam
2. Most frequently used laser besides the CO2 laser
3. This is a general surgical instrument used most of the time by general, thoracic,
plastic, and urologic surgeons
4. See absorption chart - Nd:YAG is centered between other common medical lasers
5. Unique characteristic - the "window" of low absorption
and high transmissibility
YAG is poorly absorbed by hemoglobin, chromophores, protein, or water.
6. 99% of Podiatric use is with contact laser scalpels
7. Able to coagulate vessels < 0.2 mm diameter
8. User friendly, but tip selection, type and size must be understood
9. Power settings are very important
10. Endoscopically/arthroscopically compatible
MODES OF OPERATION
1. Non-contact mode - used for debulking and treating deep tumors.
higher power levels required ie: 40 W
2. Contact-tip mode - highly localized scalpel form similar to CO2 laser
lower power ie: 12-16 W (frosted tip)
4-6 W (nonfrosted)
3. Contact-tip is very superficial absorption, cutting only at the tip.
"What-you-see-is-what-you-get"
THE INSTRUMENT
1. Instrument is portable, conventional nondedicated power OK
2. C.W. mode only
3. Flashlamp excites Neodymium-doped crystal of Yttrium, Aluminum, Garnet
4. Fiberoptic delivery system, air or water cooled within the sheath
5. Large variety of handpieces, general surgical one is used
6. Large variety of contact tips, fiber and handpiece combinations
SURGICAL APPLICATIONS
CONTRAINDICATIONS
Defer these cases until the learning curve plateau is reached
1. Digital surgery - cannot justify utilization
Instrument overkill for procedure
2. Revisional surgery - actually indicated
but these surgeries carry a higher risk by default
If successful laser gets the credit
If not successful surgeon gets blammed
Public expectations of lasers are high
3. Any bone work - not FDA approved
This is not a wavelength for this
4. Medical-Legal cases - Same idea as revisional Surgery
5. Amputation - Same idea as revisional surgery
6. PVC cases - Same idea
7. Acute Trauma cases - no time to call in laser team
INDICATIONS FOR FROSTED AND NONFROSTED CONTACT TIPS
REALISTIC EXPECTATIONS
1. Learning curve is steeper than CO2 Laser
2. Postoperative bruising still seen
3. Swelling, and pain still seen - although diminished
4. Macroscopic bleeding present but diminished
5. Be ready for the unexpected -
New technology presents new situations
6. Do simple cases first
THE ARGON LASER
GENERAL DESCRIPTION
1. Dual wavelength output:
Blue 488 nm
Green 514 nm very close to KTP 532 nm (pure green)
2. 1 to 2 mm depth of penetration.
3. Operates as a coagulation device, not used for cutting
4. Argon and KTP pass epidermis to absorb in the dermal hemoglobin selectively
Nd:YAG and CO2 do not absorb in the region of the Hb curve
5. Fiberoptic delivery system
6. collimated handpiece, freebeam fiber, contact
7. Aiming beam is a low power argon beam, hard to see through OD 3 or 5 glasses
8. 30 degree divergence on the KTP fiber, 2 degree divergence on the Argon fiber.
9. 488 nm filter is used to filter out green component
10. Hemoglobin Absorption is a bimodal curve
11. Ideally the wavelength should fall on the peak absorption of this curve and be
maximally transmissible through other tissues
MECHANISM OF ACTION
1. Chromophores on the bottom of the foot are minimal
2. They pose little problem because the epidermis, dermis
basal layer is transparent to this wavelength
3. Absorption at this wavelength is low
first absorbed in the hemoglobin within the vessels of the reticular dermis
4. vessels are stenosed via selective photoablation.
a. Able to coagulate vessels less than 1 mm in diameter.
b. Indicated for tissue coagulation and necrosis procedures (acisional)
c. KTP laser, 532 nm can be used also for vascular stenosis.
d. Deeper dermal structures, such as capillary hemangioma, other lasers are indicated
for this such as the free beam Nd:YAG.
EYE PROTECTION
1. Optical Density (O.D.) minimum of 5 at 488 nm.
2. Unfortunately, these glasses block out the aiming beam
The aiming beam is a low level intensity treatment beam.
3. Visible light eye protection radically alters the colors of the surgical field
SURGICAL APPLICATIONS
INDICATIONS FOR THE ARGON LASER
1. This treatment is very useful for incisionless surgery
It is highly favored by the patient,
particularly in the large verrucae on the plantar aspect of the foot and the posterior
aspect of the heel normally a CO2 laser would leave an ulcerative defect Immediate
shoe gear
2. Multiple disseminating lesions or mosaic warts on the plantar foot
3. Vascular lesions of a superficial nature
ADVANTAGES
1. Minimal exposure to blood--this is an incisionless procedure.
2. Decreased laser plume about 5% of that with CO2 laser A smoke evacuator is still
required
3. Good treatment for immunocompromised patients
4. Faster than CO2 laser, i.e. a 45 minute procedure for the CO2 laser for
verruca plantaris would take 5 minutes with the Argon laser
5. It is repeatable
6. Sterile preparation unnecessary.
Surgeon still should be gloved for isolation from lesion contaminants.
NOTES:
1. Some carbonization is normal in thick epidermis
Avoid charring this by continuous circular motions.
2. When blanching occurs, this is the proper setting.
Also the proper rate of hand piece movement.
3. This is a time dependent phenomena.
4. After the vasculature is coagulated the chromophores have absorbed the wavelength.
5. If blanching is not encountered, do not increase power,
do not slow down handpiece movement.
6. Repeat the same movement of the handpiece over the area.
7. When proper parameters are determined, continue treatment beyond the test area.
8. The result is not only power and spot size, giving P.D., but time dependent.
POSTOPERATIVE CARE
1. Accommodative pad prn
No dressing necessary.
Patient can put his shoe and sock on and walk out of the operating room.
2. Hydrocodone 2.5 mg i-ii Q 4-6 h prn pain
3. Blistering likely to occur in 3 to 5 days.
Patient may incise and drain this at home.
After I&D, patient is to leave the skin on, for a protective barrier.
4. At one week a black necrotic skin component will form
This lasts 3 weeks and spontaneously sheds.
5. Check patient in 3-4. Recheck in 10 weeks.
6. Should fully heal within 4 to 5 weeks.
No scarring should be seen.
A slight hypopigmentation may be observed.
7. Ulceration is not possible with this laser as the chromophores, hemoglobin
and oxyhemoglobin stops the absorption in the superficial papillary plexus.
FIBER PREPARATION
Fiber preparation is done previous to each case
1. Fiber must be cleaved:
a. Optical fibers have a crystalline nature
b. A cleaver is used to penetrate the sheath and score the fiber cortex this sets up a
stress riser so the fiber can be snapped
c. the end of the fiber is inspected for a flat, even surface
emitted laser light should be circular and symmetrical
d. The sheath must be stripped.
e. 4 mm recommended by manufacturer, but emits too much lateral light
f. so strip 2-3 mm instead, but enough so the sheath doesn't melt
g. So leave it to Cleaver to strip off the sheath for fiber preparation
SURGICAL APPLICATIONS
KTP TREATMENT OF VERRUCA
1. Same as for Argon
2. Treatment is slightly deeper
3. Blanching is similar but has more significance of penetration depth
Ho:YAG LASER
1. a near-contact laser being used for resecting calcaneal spurs
2. good for endoscopic and arthroscopic work
3. transmits through water
4. also indicated for cartilage ablative procedures for joint restoration
Q-SWITCHED LASERS
1. used to be used in ophthalmic procedures
2. Q-switched Ruby and Q-switched Nd:YAG for tatoo removal
3. no anesthesia necessary
4. multiple treatments necessary
5. little scarring results, mild hypopigmentation
EXCIMER LASER
1. UV laser, 0.2 mm absorption
2. Ionizing radiation
3. Cardiac catheterization, osteotomy, corneal sculpting
4. High frequency, short wavelength means high precision
Er:YAG LASER
1. Mid infrared, 0.1 mm absorption
2. Bone surgery
3. Difficulty in fiberoptic delivery - fragile and toxic
BIBLIOGRAPHY
1. Arndt, Kenneth A., "Argon Laser Therapy of Small Cutaneous Vascular Lesions",
Journal of the American Academy of Dermatology, vol. 118, April 1982, pp. 220-224.
2. Borovoy, Mathew; Fuller, Terry A.; Elson, Lawrence M.; Laser Safety in Podiatry", The
Journal of Foot Surgery, 1985, vol. 24, no. 2, pp. 136-138.
3. Borovoy, Mathew; Klein, Jeffery T.; Fuller, Terry A.; "Carbon Dioxide Laser
Methodology for Ablation of Plantar Verrucae", vol. 24, no. 6, 1985, pp. 431-437.
5. Carlson, Bruce A., and Pyrcz, Robert A., "Lasers in Podiatry and Orthopaedics",
Nursing Clinics of North America, v. 25, No. 3, September 1990, Pg. 719-723.
6. Carlson, Bruce A.; Pyrcz, Robert; "Human Papilloma Virus-Induced Lesions: Their
Treatment and the Evolution of an Alternative Laser Application", Current Podiatric
Medicine, November 1989, pp.9-12.
7. Carlson, Bruce A., "Complications Associated with Laser Surgery", Clinics in Podiatric
Medicine and Surgery, vol. 4, no. 4, October 1987, pp. 823-828.
8. Chromey, Paul A., "The Significance of Power Density in Applying the CO2 Laser",
Current Podiatric Medicine, September 1986, pp. 20-22.
9. Chromey, Paul A., "The Application of CO2 Laser to Soft Tissue Tumors", Current
Podiatric Medicine, May 1986, pp.24-27.
10. Collis, Sheldon; Rowland, Roberta N.; "Lasers For Podiatry Principles and
Language", Current Podiatry, April 1984, pp. 33-34.
11. Kaplan, Isaac, "The CO2 Laser In Clinical Surgery: Past, Present, and Future",
Journal of Clinical Laser Medicine and Surgery, pp. 341-343, vol. 9, no. 5, 1991.
12. Kelly, Peter F.; "Nd:YAG Contact-Tip Laser Reduces Pain from Foot Surgery",
Clinical Laser Monthly, Volume 10, No. 1, January, 1992.
13. Kelly, Peter F., "Nd:YAG Contact Tip V. Cold Steel Applications in Podiatric Foot and
Ankle Surgery", American Society for Laser Medicine and Surgery, Supplement 4, 1992.
14. Kelly, Peter F.; "The Light Scalpel - Nd:YAG Laser Contact-Tip", Issue 24, 1992, The
Laser Letter, International Society of Podiatric Laser Surgery, Doylestown, PA.
15. Kelly, Peter F.; "The Nd:YAG Laser for the Podiatric Surgeon", The Laser Letter,
Issue 25, 1992, International Society of Podiatric Laser Surgery, Doylestown, PA.
16. Kelly, Peter F.; "KTP Laser Application to Calcaneal Spur Surgery", Clinical Laser
Monthly; Volume 11, No. 3, April, 1993.
17. Kelly, Peter F., "KTP Laser Application to Calcaneal Spur Resection and Plantar
Fasciectomy", American Society for Laser Medicine and Surgery, Supplement 5, 1993
18. Landsman, Mark J.; Mancuso, John E.; Abramow, Steven P.; "Laser's Use in Bone
and Joint Surgery, Clinics in Podiatric Medicine and Surgery, vol. 9, no. 3, July 1992, pp.
721-737
19. McDowell, Brian A., "Carbon Dioxide Laser Excision of Benign Pedal Lesions,
Clinics in Podiatric Medicine and Surgery, vol. 9, no. 3, July 1992, pp. 617-632.
20. Mueller, Terrance J.; Carlson, Bruce A.; Lindy, Marc P.; "The Use of the Carbon
Dioxide Surgical Laser for the Treatment of Verrucae", Journal of the American Podiatry
Association, vol. 70, no. 3, March 1980, pp. 136-141.
21. Nicholson, Ronald A., "Two Techniques Described using C02 Laser for
Matrixectomy", Laser Practice Report, vol. 7, no. 7, pp. 1 S-2S.
22. Pyrcz, Robert A.; Carlson, Bruce A.; "Lasers in Podiatry and Orthopedics", Nursing
Clinics of North America, vol. 25, no. 3, September 1990, pp. 719-723.
23. Wasserman, Gerald, "Treatment of Morton's Neuroma with the Carbon Dioxide
Laser", Clinics in Podiatric Medicine and Surgery, vol. 9, no. 3, July 1992.
SPEED-READING BIBLIOGRAPHY
1. "Continued efforts to enhance the utilization of laser technology and the ability of laser
education at teaching hospitals are key for the future." Lanzafame, Raymond, J.;
Hinshaw, Raymond, J.; "Laser Education, Laser Usage, and Surgical Attitudes: A
Challenge for the Future", Pg. 279-81, Journal of Clinical Laser Medicine and Surgery,
Volume 10, No. 4, 1992.
2. "It (the CO2 laser) routinely provides a bloodless surgical field as well as unusual
surgical precision." Fairhurst, Mark V.; Roenick, Randall K.; Brodland, David G.;
Subspecialty Clinics: Dermatology, "Carbon Dioxide Laser Surgery for Skin Disease",
Mayo Clinical Proceedings, Vol. 67, Pg. 49-58, 1992.
5. "Since the beam affects well defined areas of the skin, there is minimal necrosis of
adjacent tissue; consequently, postoperative pain, edema, and scarring are minimized."
Mueller, Terrance J.; Carlson, Bruce A.; Lindy, Mark P.; "The Use of the Carbon Dioxide
Surgical Laser for the Treatment of Verrucae", Journal of the American Podiatry
Association, Vol. 70, No. 3, March 1980, Pg. 136-141.
6. "Podiatry started using the laser for the excision of Morton's neuroma and for
incisional approaches to bunionectomy and other podiatric procedures." "The same
advantages were found to be present for incisional procedures: less bleeding, pain, and
postoperative edema." Peyrcz, Robert A., Carlson, Bruce A., "Lasers In Podiatry and
Orthopedics", Nursing Clinics of North America, Vol. 25, No. 3, September 1990, Pg.
719-723.
7. "Utilizing the CO2 laser in neuroma surgery for making incisions and sealing the nerve
stump decreases postoperative pain and healing, allowing patients to resume normal
ambulation faster than with conventional scalpel surgery." Wasserman, Gerald, Clinics
in Podiatric Medicine and Surgery, "Treatment of Morton's Neuroma With the Carbon
Dioxide Laser", Vol. 9, No. 3, July 1992, Pg. 671-686.
8. "The contact method of performing endoscopic and open surgery with the Nd:YAG
laser opens a new era in laser surgery ... with cutting capabilities previously only seen
with the CO2 laser." "The CO2 laser operating at a wavelength of 10,600 nm with energy
outputs of 100 watts is effective at cutting and coagulation of SUPERFICIAL blood
vessels." Joffe, Stephen N.; Schroder, Tom; Lasers in General Surgery, Year Book
Medical Publishers, Inc., Laser Center of America, Cincinnati, OH, Pg. 125-130, 1987.
9. "We concluded that CO2 laser surgery for hemophiliacs has a confirmed place for
modern laser technology." Santo-Dias, A.; "CO2 Laser Surgery in Hemophilia
Treatment", Journal of Clinical Laser Medicine and Surgery, Pg. 297-301, Volume 10,
No. 4, 1992.
10. "Because of the large amount of water in body tissue, this laser (CO2) will cause a
vaporization of the tissue at the focal point and seal the small blood vessels and
lymphatics. The laser creates an incision that leaves residual tissue undamaged."
Kaplan, Isaac; "Twenty Years of CO2 Laser Surgery: A Review and Update", Journal of
Clinical Laser Medicine and Surgery, Pg. 57-60, Volume 11, No. 2, 1993.
11. "Certain advantages of the use of the CO2 laser stand out: absence of hemorrhage
and cellular vaporization which permit, due to a perfect visibility, appreciation at every
moment of the quantity of tissue that needs to be removed." Dourov, Nicolas; Nammour,
Samir; "Removal of Benign Tumors Using the CO2 Laser", Journal of Clinical Laser
Medicine and Surgery, Pg. 109-113, Volume 10, No. 2, 1992.
12. "This action results in a fine hemostatic incision leaving the residual tissue relatively
undamaged." "The treated areas heal rapidly because the skin appendages escape
permanent damage." Kaplan, Isaac; "The CO2 Laser In Clinical Surgery: Past, Present,
and Future", Journal of Clinical Laser Medicine and Surgery, Pg. 341-343, Volume 9,
No. 5, 1991.
13. "Surgical laser technology has been available for nearly 30 years and is being used
increasingly in many surgical disciplines including orthopedic surgery." Cahill, Sandy;
Kopta, Joseph A.; Kosanke, Stanley D.; Rayan, Ghazi M.; Stanfield, Denver T.; "Effects
of Rapid Pulsed CO2 Laser Beam on Cortical Bone In Vivo", Lasers in Surgery and
Medicine, Pg. 615-620, Volume 12, No. 6, 1992.
14. "The lack of wound contraction, scarring, and good reepithelialization combined with
precise tissue destruction makes CO2 laser surgery ideal for this procedure when
compared with conventional techniques." Keng, S. B.; Loh, H. S.; "The Treatment of
Epulis Fissuratum of the Oral Cavity by CO2 Laser Surgery", Journal of Clinical Laser
Medicine and Surgery, Pg. 303-306, Volume 10, No. 4, 1992.
15. "The advantage of the CO2 laser technique was that it produced minimal thermal
damage to the surrounding tissues." Fallouh, Hayel; Sultan, Raymond A.; "Combined
CO2-Nd:YAG Radiation in Liver and Anorectal Diseases", Journal of Clinical Laser
Medicine and Surgery, Pg. 255-263, Volume 10, No. 4, 1992.
FURTHER READING
2. Ballow, Edward B., D.P.M., Editor, Laser Surgery of the Foot, First Edition,
International Society of Podiatric Laser Surgery, Doylestown, PA, 1988.
3. Joffe, Stephen N.; Schroder, Tom; Lasers in General Surgery, Year Book Medical
Publishers, Inc., Laser Center of America, Cincinnati, OH, 1987.
4. "Lasers In Podiatry and Orthopedics", Nursing Clinics of North America, Vol. 25, No.
3, September 1990.
PHOTODYNAMIC THERAPY "PDT"
MECHANISM OF OPERATION
1. Requires an injection, dissemination and systemic absorption of protoporphyrins
2. Malignant cells take up the protoporphyrin
These can be visualized under UV light
Patient must remain away from all light during this treatment session and have a
photosensitivity up to six weeks post treatment
3. Laser radiation is applied at a specified frequency, usually red light area. and for a
specified time - result is Joules to tissue
4. Wavelength depends on protoporphyrin
5. Results is a single oxygen produced which destroys malignant tissue selectively
BIOSTIMULATION "BIOSTIM"
1. A few milliwatts hitting mitochondria stimulating thermal mechanism.
2. No heat is produced.
3. Mitochondrial chromophores.
4. This is FDA investigational.
5. Applied to wound healing, to nerve regeneration, and chronic pain--analgesic.
6. Elicits a systemic effects
7. 0 milliwatts, tunable dye, helium-neon, 12 joules per week for 30 weeks
8. Applied to rheumatoid arthritis, trigeminal neuralgia, osteoarthritis, sciatica, diabetic
neuropathy.
9. Has 60 to 85% of pain relief
10. 5-hydroxyindolacetic acid, 5-HIAA produced
Urinary HIAA output increase correlated with pain relief
11. Systemic effects:
stimulation of human lymphocytes
Decreased pain and inflammation of distant ion irradiated sites Increased urinary 5-
HIAA, product of serotonin metabolism
12. Dose:
50 milliwatts, tuneable dye or helium-neon laser, 12 joules per week for 30 weeks.
13. Proposed mechanism:
absorption of light by photoreceptor or chromophore in the mitochondria activates the
respiratory chain, resulting in a cellular response.
14. Primary process:
a. Electron train excitation
b. acceleration of electron transfer in redox pairs (activates and stimulates).
c. Transfer of excitation energy from oxygen
to single oxygen (oxidative effect inhibiting healing).
d. Respiratory chain components are probably the primary photoacceptors.
e. Flavins, cytochromes, cytochrome oxidase.
f. Respiratory chain in a unitary dynamic system can be acted upon
at various points causing change in the whole state of response.
Summary:
1. Effects are dose dependent. Higher energies seem to be damaging.
2. Coherent light is preferred versus non-coherent.
3. Narrowed band monochromatic light preferred, i.e. helium-neon coherent and
monochromatic light
4. Competing wavelengths cancel the effects, therefore coherent light is preferred.
5. Transcutaneous irradiation penetrates deeply enough to
produce generalized effect in many cases.
6. 4 joules/cm2 penetrates approximately 1 cm.
7. Local radiation with systemic effects.
i.e., 5-HIAA production from serotonin metabolism.
8. Depends upon the physiological status of cell before radiation.
9. The biostimulation effect is not always possible.